3 Perfect Stocks for Retirees to Buy Hand Over Fist During the Nasdaq Bear MarketThe Motley Fool • 01/26/23
3 Reasons Why Johnson & Johnson Stock Could Rebound After a Bad Start in 2023The Motley Fool • 01/25/23
Johnson & Johnson's 4Q earnings beat and rosy 2023 outlook fails to distract from slowing sales growth and inflationary pressuresProactive Investors • 01/24/23
‘Tripledemic' demand for Motrin and Tylenol fueled year-end sales in J&J's consumer businessMarket Watch • 01/24/23
Johnson & Johnson Beats Profit Views, But Light Sales, Outlook Chip At SharesInvestors Business Daily • 01/24/23